Rationale, Design, and Synthesis of Novel Phenyl Imidazoles as Opioid Receptor Agonists for Gastrointestinal Disorders
Henry J. Breslin(Springhouse), Wei He(Hebei Medical University), Nathaniel Wallace(Johnson & Johnson (United States)), Rebecca P. Martinez(Johnson & Johnson (United States)), Tamara A. Miskowski(Janssen (United States)), Raymond W. Colburn(Johnson & Johnson (United States)), Bryan M. Rafferty(Johnson & Johnson (United States)), Sui‐Po Zhang(Johnson & Johnson (United States)), Li J(Johnson & Johnson (United States)), Jeffrey M. Palmer(Johnson & Johnson (United States)), Dennis J. Stone(Johnson & Johnson (United States)), Craig R. Schneider(Johnson & Johnson (United States)), Edward S. Kimball(Johnson & Johnson (United States)), Santosh V. Coutinho(Johnson & Johnson (United States))
Cited by 23
Related Papers
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus
|Nature Genetics|2009|944
<i>C</i>-Glycosidation Technology With Free Radical Reactions
|Synlett|1998|151
Early-Onset Preeclampsia Is Associated With Gut Microbial Alterations in Antepartum and Postpartum Women
|Frontiers in Cellular and Infection Microbiology|2019|150
Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist
|British Journal of Pharmacology|2012|121